News | News By Subject | News by Disease News By Date | Search News

Weight Loss News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
GlaxoSmithKline (GSK) Best-Selling Weight Loss Pill Cramped By Problematic Studies That Understated Its Harms     8/17/2016
After Patient Death in Zafgen (ZFGN)'s Phase III Obesity Study, FDA Places Partial Hold on Trial     10/16/2015
Ralph Lauren Smart Shirt Will Measure Heart Rate And Calories Burned     8/31/2015
Rhythm Metabolic Banks $40 Million Series A     8/13/2015
VIVUS (VVUS) Slashes Workforce as Obesity Market Shrinks     8/4/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Helsinn Group Release: Pivotal Phase 3 Trial Data For Anamorelin In ROMANA 1 And 2 Studies In Non-Small Cell Lung Cancer Patients With Anorexia-Cachexia Shows Significant Increase In Lean Body Mass, Body Weight And Improved Symptoms     9/29/2014
FDA Approves Orexigen (OREX)'s Long-Awaited Weight Loss Drug Contrave     9/12/2014
Orexigen Therapeutics, Inc. (OREX)'s Diet Pill Contrave May Get FDA Approval This Week     6/10/2014
Novo Nordisk A/S (NVO) Release: Phase 3a Data From Largest Trial With Liraglutide 3 Mg Demonstrated Significantly Greater Weight Loss Versus Placebo For Adults With Obesity     5/16/2014
VIVUS, Inc. (VVUS)'s Diet Pill Faces Generic Threat From Actavis (ACT)     5/12/2014
Boston-Based Intarcia Therapeutics, Inc. Grabs $200 Million To Beef Up Pipeline     4/1/2014
GlaxoSmithKline (GSK) Recalls Weight-Loss Drug Alli In U.S. After Tampering     3/27/2014
FDA Approves Bristol-Myers Squibb Company (BMY)' Drug For Rare Fat Disorder     2/26/2014
Zafgen's Obesity Drug Clears A Hurdle, Helps Patients Lose Up To 24 Pounds In Phase 2 Study     11/18/2013

News from Around the Web
Will You Lose Weight? Take A Look At Your Poop, University of Copenhagen Study Reveals     9/19/2017
This App Will Analyze Your DNA To Help You Lose Weight     7/31/2017
New Breathalyzer That Measures Fat-Loss Is Now Available In Seattle     3/6/2017
Could A Little Bit Of Fasting Bring A Lot Of Health Benefits? University of Southern California Study     2/17/2017
The Idea That Some People Don't Respond To Exercise Might Just Be A Myth, Journal of Physiology Reveals     2/6/2017
Does Intermittent Fasting Boost Your Metabolism?     11/30/2016
Fitness Trackers May Not Help People Keep Weight Off Long-Term     9/21/2016
Researchers Target Gut Bacteria To Reduce Weight Gain, Vanderbilt University Study     8/29/2016
Trick To Cutting Calories: Order Your Food One Hour Before It's Time To Eat, Carnegie Mellon University Study     7/21/2016
Enjoy That Pasta Salad: Noodles Linked To Lower BMI     7/5/2016
Copper Is Key In Burning Fat, Lawrence Berkeley National Laboratory Study Reveals     6/7/2016
High-Fat Mediterranean Diet Does Not Cause Weight Gain, The Lancet Diabetes & Endocrinology Journal Reveals     6/7/2016
This Weight Loss Pill Inflates A Balloon In Your Stomach, Obalon Reveals     5/25/2016
Beer Compound Lowers Cholesterol, Blood Sugar And Weight Gain, Oregon State University Study     4/25/2016
One Antidepressant Shown To Control Weight During 2-Year Study, Group Health Research Institute Reveals     4/21/2016

Press Releases
Eisai Inc. (ESALF.PK) Announces Lorcaserin HCl CAMELLIA-TIMI 61 Study Will Continue As Planned Based On Interim Safety Analysis By Independent Data Monitoring Committee (DMC)     6/21/2017
Digestive Disease Week Release: Non-Surgical Weight-Loss Treatment Found Safe, Effective For Those With Limited Options     5/9/2017
Novo Nordisk A/S (NVO) Receives FDA Approval Of Saxenda (Liraglutide) Injection 3 Mg Label Update Including Long-Term Safety And Efficacy Data From 3-Year Trial     4/27/2017
New Breathalyzer That Measures Fat-Loss Is Now Available In Seattle     3/6/2017
BAROnova Release: Company Announces Completion of ENDObesity II Pivotal Clinical Trial Enrollment     1/26/2017
Neothetics (NEOT) Initiates Phase 2 Proof Of Concept Trial For LIPO-202 For The Reduction Of Submental Subcutaneous Fat     12/27/2016
Eisai Inc. (ESALF.PK) And Arena (ARNA) Announce Regulatory Approval Of BELVIQ (Lorcaserin Hcl) In Brazil     12/19/2016
Commercial Patient Data Confirms Success of EnteroMedics (ETRM)' vBloc Therapy In Combination With vBloc Achieve Program In Patients Struggling To Lose Weight     12/15/2016
The Journal of the American Osteopathic Association Release: Researchers Find Low-Carb Diets Safe In Short Term And Slightly More Effective For Weight Loss Than Low Fat Diets     12/14/2016
Orexigen (OREX) Announces Commercialization And Distributorship Agreement With Consilient Health Ltd. For Mysimba (Naltrexone Hcl / Bupropion Hcl Prolonged Release) In The UK And Ireland     12/8/2016
Aspire Bariatrics Release: AspireAssist Pivotal Trial Results Published In The American Journal Of Gastroenterology     12/7/2016
Nature's Research Journal Scientific Reports Proves Noom Coach Is Effective In Driving Sustained Weight Loss Across Large Populations     11/16/2016
Eisai Inc. (ESALF.PK) And Arena (ARNA) Announce Availability Of Once-Daily BELVIQ XR (Lorcaserin Hcl) Extended-Release Tablets     10/3/2016
KVK Tech Announces FDA-Approval Of Lomaira (Phentermine Hydrochloride USP) 8 Mg Tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up To Three Times Daily For Weight Reduction     9/20/2016
vBloc Institute Demonstrates Positive Clinical Success In Patients Struggling With Weight Loss As Compared To Pivotal FDA Trial With EnteroMedics (ETRM) VBloc Therapy In Combination With VBloc Achieve Program     9/13/2016